Lineage Cell Therapeutics, Inc.LCTXNYSE
Loading
Total value of everything the company owns
3Y CAGR
-3.1%/yr
vs +5.0%/yr prior
5Y CAGR
+0.8%/yr
Recent deceleration
Acceleration
-8.1pp
Decelerating
Percentile
P57
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
1 yr
Consecutive declineStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $112.58M | -0.6% |
| 2024 | $113.22M | +12.1% |
| 2023 | $101.02M | -18.3% |
| 2022 | $123.66M | -29.2% |
| 2021 | $174.54M | +61.7% |
| 2020 | $107.95M | -14.0% |
| 2019 | $125.48M | +23.4% |
| 2018 | $101.66M | -41.3% |
| 2017 | $173.24M | +21.5% |
| 2016 | $142.57M | - |